$23MSeries B, 18 November 2025
Funds clinical development of the A-FLUX system, including the SERRA-I feasibility study.
- Amount
- $23M
- Stage
- Series B
- Announced
- 18 November 2025
- Lead
- S3 Ventures
- Other investors
- Intuitive Ventures
- Use of funds
- Funds clinical development of the A-FLUX system, including the SERRA-I feasibility study.
- Checked
- Announced by the company
- Sources
- VahatiCor raises $23M Series B businesswire.com
VahatiCor raises $23M Series B newsletter.parsers.vc